Tomoko Seki

593 total citations
43 papers, 439 citations indexed

About

Tomoko Seki is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Tomoko Seki has authored 43 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Cancer Research and 8 papers in Surgery. Recurrent topics in Tomoko Seki's work include Breast Cancer Treatment Studies (10 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Treatment and Pharmacology (5 papers). Tomoko Seki is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), HER2/EGFR in Cancer Research (5 papers) and Cancer Treatment and Pharmacology (5 papers). Tomoko Seki collaborates with scholars based in Japan, United Kingdom and Egypt. Tomoko Seki's co-authors include Tetsu Hayashida, Maiko Takahashi, Yuko Kitagawa, Aiko Nagayama, Akiko Matsumoto, Hiromitsu Jinno, Takeshi Murata, Sadaki Inokuchi, Yuko Kitagawa and Isao Ishikawa and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Critical Care Medicine.

In The Last Decade

Tomoko Seki

36 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoko Seki Japan 14 145 126 104 80 49 43 439
Harald Lass Austria 8 150 1.0× 101 0.8× 75 0.7× 53 0.7× 54 1.1× 13 514
Søren Krag Denmark 15 97 0.7× 116 0.9× 104 1.0× 89 1.1× 145 3.0× 26 480
Gülgün Erdoğan Türkiye 12 81 0.6× 47 0.4× 74 0.7× 60 0.8× 99 2.0× 41 358
Harman Sekhon Canada 16 115 0.8× 116 0.9× 92 0.9× 367 4.6× 91 1.9× 40 643
Alexandre de Nonneville France 12 221 1.5× 86 0.7× 193 1.9× 115 1.4× 78 1.6× 63 443
Jen‐Pin Chuang Taiwan 11 214 1.5× 140 1.1× 40 0.4× 72 0.9× 62 1.3× 25 407
Cyril Foa France 12 181 1.2× 80 0.6× 74 0.7× 181 2.3× 67 1.4× 31 457
Erdem Çubukçu Türkiye 12 253 1.7× 37 0.3× 103 1.0× 75 0.9× 106 2.2× 51 481
Klaus K. Andersen Denmark 12 124 0.9× 62 0.5× 96 0.9× 64 0.8× 156 3.2× 16 472
Cecilia Bosco United Kingdom 9 94 0.6× 98 0.8× 113 1.1× 250 3.1× 102 2.1× 23 543

Countries citing papers authored by Tomoko Seki

Since Specialization
Citations

This map shows the geographic impact of Tomoko Seki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Seki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Seki more than expected).

Fields of papers citing papers by Tomoko Seki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Seki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Seki. The network helps show where Tomoko Seki may publish in the future.

Co-authorship network of co-authors of Tomoko Seki

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoko Seki. A scholar is included among the top collaborators of Tomoko Seki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoko Seki. Tomoko Seki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masuda, Kenta, Tomoko Seki, Minoru Kitago, et al.. (2025). Potential New Tumors Associated with Hereditary Breast and Ovarian Cancer (HBOC). The Keio Journal of Medicine. 74(3). 158–161.
2.
Masuda, Kenta, Yusuke Kobayashi, Tomoko Seki, et al.. (2025). Current Situation and Future Directions of Risk-reducing Salpingo-oophorectomy. The Keio Journal of Medicine. 74(3). 138–145.
3.
Takahashi, Kaori, Ryuji Uozumi, Toru Mukohara, et al.. (2024). Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer. The Oncologist. 29(6). e741–e749. 6 indexed citations
4.
Nakao, Mayumi, Hiroko Komatsu, Tetsu Hayashida, et al.. (2022). The relationship between work-related outcomes and symptoms in early breast cancer survivors receiving adjuvant endocrine therapy. Asia-Pacific Journal of Oncology Nursing. 9(3). 174–178. 2 indexed citations
5.
Hayashida, Tetsu, Aiko Nagayama, Tomoko Seki, et al.. (2022). Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system. Cancer Science. 113(5). 1722–1730. 8 indexed citations
6.
Hayashida, Tetsu, Takeshi Murata, Aiko Nagayama, et al.. (2021). A transposon screen identifies enhancement of NF-κB pathway as a mechanism of resistance to eribulin. Breast Cancer. 28(4). 884–895. 7 indexed citations
7.
Hayashida, Tetsu, Shigeo Yamaguchi, Yuko Kawai, et al.. (2021). Comprehensive analysis of the homeobox family genes in breast cancer demonstrates their similar roles in cancer and development. Breast Cancer Research and Treatment. 186(2). 353–361. 3 indexed citations
8.
Hayashida, Tetsu, Yuko Kawai, Tomoko Seki, et al.. (2020). Identification of a Modified HOXB9 mRNA in Breast Cancer. Journal of Oncology. 2020. 1–10. 2 indexed citations
9.
Hayashida, Tetsu, Hiromitsu Jinno, Hiroki Sato, et al.. (2018). Phase II trial of eribulin mesylate as a first- or second-line treatment for locally advanced or metastatic breast cancer: a multicenter, single-arm trial. BMC Cancer. 18(1). 701–701. 13 indexed citations
10.
Hayashida, Tetsu, Aiko Nagayama, Tomoko Seki, et al.. (2018). Effectiveness of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-Analysis. The Oncologist. 24(6). e347–e357. 31 indexed citations
11.
Hayashida, Tetsu, Tomoko Seki, Maiko Takahashi, et al.. (2018). IgG4‐related mastopathy: A case report and literature review. Clinical Case Reports. 6(8). 1549–1553. 13 indexed citations
12.
Hayashida, Tetsu, Aiko Nagayama, Tomoko Seki, et al.. (2017). The updated network meta-analysis of neoadjuvant therapy for HER2-positive breast cancer. Cancer Treatment Reviews. 62. 9–17. 19 indexed citations
13.
Nagayama, Aiko, Tetsu Hayashida, Hiromitsu Jinno, et al.. (2014). Comparative Effectiveness of Neoadjuvant Therapy for HER2–Positive Breast Cancer: A Network Meta-Analysis. JNCI Journal of the National Cancer Institute. 106(9). 57 indexed citations
14.
Yamagiwa, Takeshi, Seiji Morita, Rie Yamamoto, et al.. (2010). Determination of the appropriate catheter length for needle thoracostomy by using computed tomography scans of trauma patients in Japan. Injury. 43(1). 42–45. 20 indexed citations
15.
Seki, Tomoko, et al.. (2010). Fibroblast Growth Factor and Insulin-Like Growth Factor Rescue Growth Cones of Sensory Neurites from Collapse After Tetracaine-Induced Injury. Anesthesia & Analgesia. 110(5). 1468–1472. 9 indexed citations
16.
Okamoto, Yoshichika, Kazuo Suzuki, Yoshihisa Shibata, et al.. (1995). Seven Cases of Obturator Hernia.. The Japanese Journal of Gastroenterological Surgery. 28(9). 1967–1971. 1 indexed citations
17.
Watanabe, Hisashi, Makoto Umeda, Tomoko Seki, & Isao Ishikawa. (1993). Clinical and Laboratory Studies of Severe Periodontal Disease in an Adolescent Associated With Hypophosphatasia. A Case Report. Journal of Periodontology. 64(3). 174–180. 40 indexed citations
18.
Seki, Tomoko, et al.. (1989). Effect of subgingival plaque control by direct irrigation technique. 2. Clinical and microbiological changes after irrigation with acrinol or benzalkonium chloride solution.. THE JOURNAL OF THE STOMATOLOGICAL SOCIETY JAPAN. 56(3). 435–443. 1 indexed citations
19.
20.
Seki, Tomoko, et al.. (1958). Tetanal Toxin obtained by Mechanical Disintegration of the Bacterial Cell.. 8(4).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harald Lass Breakdown of academic impact, for papers by Søren Krag Breakdown of academic impact, for papers by Gülgün Erdoğan Breakdown of academic impact, for papers by Harman Sekhon Breakdown of academic impact, for papers by Alexandre de Nonneville Breakdown of academic impact, for papers by Jen‐Pin Chuang Breakdown of academic impact, for papers by Cyril Foa Breakdown of academic impact, for papers by Erdem Çubukçu Breakdown of academic impact, for papers by Klaus K. Andersen Breakdown of academic impact, for papers by Cecilia Bosco
Rankless by CCL
2026